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Summary
Historical literature on portal hypertension is mainly focused on the contemporary advances 
in therapeutic methods, especially surgical ones. However, it seems that the origin of the 
human knowledge on the portal system, its association with the caval system, obstructive 
pathologies in this system and the gastrointestinal bleeding due to hepatic diseases might be 
much older than previously believed. 
Avicenna provided a detailed anatomy of the portal venous system and its feeding branch-
es in the Canon of Medicine. Soddat al-Kabed va al-Masarigha (liver and mesenteric oc-
clusion) is also a disease presented by Avicenna with clinical, etiological and therapeutic 
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descriptions suggesting the fact that Soddat al-Kabed va al-Masarigha has multiple similar-
ities with the currently identified concept of “portal hypertension”.
He presented sense of heaviness in the liver area with or without mild pain, anemia, pale and 
inappropriate body color, and loose stool which can be complicated with ascites, infection, 
fever and abdominal pain as clinical manifestations of this disease. He has also suggested 
therapeutic approaches including laxative and diuretic herbs to help excreting the obstruc-
tive material into stool or urine. 
Keywords: portal system, portal hypertension, anatomy, history of medicine, Avicenna, 
liver, traditional Persian medicine
Introduction
Portal hypertension is defined as a resistance to portal blood flow and 
augmentation of portal collateral blood flow [1]. While the resistance most 
often occurs intrahepatically, as in cirrhosis, it can also be of prehepatic (e.g. 
portal vein thrombosis) or posthepatic (e.g., Budd-Chiari syndrome) ori-
gins. The three most common causes of portal hypertension worldwide are 
cirrhosis, hepatic schistosomiasis and portal vein thrombosis [2]. Portal hy-
pertension is often asymptomatic until complications develop. The clinical 
manifestations of portal hypertension (such as ascites, variceal hemorrhage, 
spider angioma, and gynecomastia) are either related to the underlying cause 
or the complications of the portal hypertension. Management in patients 
with portal hypertension is aimed at preventing and treating its complica-
tions along with the treatment of the underlying cause [3].
Available scientific literature on history of portal hypertension is mainly 
focused on the recent developments in therapeutic methods especially sur-
gical ones [4-6]. Other reports on historical origins of the findings on the 
portal system and portal hypertension also focused on the findings from the 
16th to 20th centuries. In these cases, Vesalius is considered the first who men-
tioned the portal system in his depicted anatomical figure from this system 
(Figure 1). At a dissection session in London, Glisson became the first to have 
introduced portal vein as the vessel through which blood is collected from 
the gastrointestinal tract and returned to the systemic circulation. His tool 
was a goose quill which was inserted into the portal vein and through which, 
using a pig’s bladder, he injected milk towards liver; observing how the liver 
turned pale as the milk traversed it on its way to the vena cava and finally to 
the lungs inspired Glisson. Nineteenth century was the era in which sple-
nomegaly, ascites, and gastrointestinal hemorrhage became known due to 
obstruction to the flow in the portal system [7].
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However, it seems that the origin of the human knowledge on the portal 
system, its association with the caval system, obstructive pathologies in this 
system and the gastrointestinal bleeding due to hepatic diseases might have 
older origins. Our recent investigation revealed that the mentioned concepts 
have been presented in Avicenna’s “Canon of Medicine” in the chapter of 
hepatic diseases especially in the discussion on the disease of “Soddat al-
Kabed” (Liver occlusion).
Avicenna (Ibn-e-Sına), a Persian polymath born near Bukhara, Iran [now 
in Uzbekistan] in 980 AD, and died in Hamadan, Iran in 1037, is one of the 
most outstanding medical scholars and practitioners of all time. He influ-
enced the medical sciences immensely in the golden ages of Islamic medicine 
(9–12th century AD) [8]. He contributed to various aspects of medicine, in-
cluding gastroenterology and surgery [9]. He wrote almost 450 treatises on a 
wide range of subjects, including medicine [10]. His most important medical 
manuscript, Al-Qanoon-fil-tibb-or (The Canon of Medicine) was translated 
into Latin in the 12th century AD by Constantine of Africa and was taught 
at the western universities from the 13th to the 18th centuries AD [11-12].
Figure 1. Portal system, A: Schematic illustration of Avicenna’s description 
of the portal system in “Canon of Medicine” (980-1037 CE). B: Vesalius’s 
pictorial of the portal system (1543 CE).
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The Canon of Medicine is divided into five volumes. The chapter of 
venous system anatomy is presented in the first volume. Avicenna has dis-
cussed the portocaval venous system in this chapter. The third volume con-
tains general principles of diagnosis and treatments of diseases of different 
organs. The 14th chapter of this volume, “On the diseases of the liver” is de-
voted to discussion on hepatic diseases. The clinical, etiological and thera-
peutic description of Avicenna on the disease of “Soddat al-Kabed” in this 
chapter shows multiple similarities with the concept which is known today 
as portal hypertension. The current study reviews Avicenna’s point of view 
on the portocaval venous system and its obstruction. 
Description of portal the system in 
Avicenna’s Canon of Medicine
A detailed anatomy of the portal venous system and its feeding branches 
has been provided by Avicenna in the Canon of Medicine (Figure 1) [13].
“And in the anatomic description of vein entitled “Bab” (portal vein), we say, 
portal vein, in the hilum of liver, divide into five branches that consequently 
divide into smaller branches. These are finally drained in vein in convex part 
of liver (hepatic vein). The gallbladder vein is branched from these branches 
of portal vein (cystic vein). And these branches are like branches of a stem of 
a tree.”
“And other side of the vein divides into eight branches. Two branches are 
smaller while the remaining six are larger. One of small branches con-
nects to “Esna ashar” (duodenum) to absorb the food, and some branches 
to “Angheras” (pancreas) stem from this vein (pancreaticoduodenal veins). 
Another small branch goes to the inferior of stomach and “Bavab” of stom-
ach (pyloric vein).” 
“And of six left branches, the first goes to superficial part of stomach (left gas-
tric vein) …, the second one goes to the spleen (splenic vein) and some branch-
es to “Angheras” (pancreas) leave it before reaching the spleen (pancreatic 
branches of splenic vein), and in entrance part of this vein to spleen a branch 
is split to the left side of stomach. In the spleen this vein is also divided into 
ascending and descending branches; some branches to the left side and car-
dia of stomach are divided from the ascending branch (short gastric veins) ... 
[and] from the descending branch another branch originates towards the left 
side of omentum (left gastroepiploic vein).”
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“And the third one goes to a venous plexus around the sigmoid (sigmoid vein) 
while the fourth stretches to the right side of stomach and omentum (right 
gastroepiploic vein)…. The fifth distributes in colon (colic veins) and the sixth 
scatters around the ileum and cecum (ileocolic vein).”(vol. 1, p.90-91) [13]
As can be seen, Avicenna has made a comprehensive description of feed-
ing branches of portal vein in this section. He has also mentioned multiple 
branches precisely matching the current anatomical knowledge of these 
veins. However, he has described some branches with different classifica-
tions. Avicenna has also presented the anatomic and physiologic association 
between portal and hepatic vein through liver sinusoids. 
“From the pores of “Masarigha” (mesenteric veins) the absorbed food goes 
toward the liver from the smaller branches to larger up to reach the “Bab” 
(portal vein). [Then] this vein divides into hair-like branches inside the liver 
and the liver tissue transfers the absorbed material to blood. Another vein 
originates from the convex side of liver whose stem also divides into hair-like 
branches connecting with branches from portal vein; through these branches 
blood goes from the smaller ones to larger ones up to collect whole blood 
into the vein having originated from the convex of liver [hepatic vein].”(vol. 
1, p.90-91) [13]
“Soddat al-Kabed” clinical descriptions from Avicenna
Described in the 14th chapter of 3rd volume of Canon of Medicine, i.e. “On 
the Diseases of the liver”, Soddat al-Kabed va al-Masarigha (liver and mes-
enteric occlusion) has been comprehensively described by Avicenna; he 
focuses on the clinical, etiological and therapeutic concepts of this disease 
suggesting the fact that Soddat al-Kabed has multiple similarities with the 
currently identified concept of “portal hypertension”.
“The occlusion may happen in liver veins, due to abnormality in the veins 
such as their congenital stricture or abnormal flowing contents. The occlu-
sion is more prevalent in pre hepatic and portal vein branches than post he-
patic and hepatic vein branches, because the obstructive materials at first 
reach the portal branches.”(vol. 3, p.183) [13]
Avicenna described the manifestations of the disease as sense of heavi-
ness in the liver area with or without mild pain, anemia, pale and inappro-
priate body color and loose stool as the clinical manifestations of this disease 
[13]. He also has mentioned ascites, infection, fever and abdominal pain as 
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the possible complications of this disease. It seems that he is describing the 
clinical characteristics of secondary bacterial peritonitis in this part:
“… and [when] occlusion progresses [, it] leads to ascites and infections which 
cause fever and severe abdominal pain …”(vol. 3, p.183) [13]
He mentioned dyspnea as a consequence of this disease, comparable to 
what is known today as different complications of portal hypertension; for 
instance hepatic hydrothorax, hepatopulmonary syndrome or portopulmo-
nary hypertension.
“The occlusion may be followed by dyspnea because the respiratory system 
has strong association with liver.”
Avicenna does not mention bloody stool in the chapter of the disease 
“Soddat al-Kabed”. However, he refers to symptoms which are suggestive of 
variceal bleeding in the chapter of the liver dystemperament.
“… Some times in the late stages of the disease the stool became similar to 
burned blood, not fresh one …”(vol. 3, p.170) [13]
In another chapter, “Ekhtelaf al-Dam” (The bloody stool), he describes 
the differentiating symptoms of bloody stool caused by intestinal bleeding 
from the hepatic sources.
“The intestinal source bleeding is concomitant with abdominal cramp and is 
different from hepatic source bleeding which is painless and relapsing. Each 
relapse is worse and severer. The symptoms of liver diseases are also present 
in hepatic source bloody stool.”(vol. 3, p.266) [13]
He recommended against the use of astringents in the treatment of loose 
bloody stool with hepatic occlusive origins. According to his belief, such 
drugs might aggravate hepatic occlusions:
“It has occurred for multiple times that thoughtless physician-like people 
have used astringents in patients with liver occlusion which has ultimately 
led to blood thrombosis in patients’ bodies, followed by the collapse of liver 
natural heat and death… Hence, when you diagnose the liver or mesenteric 
occlusion, you should focus on its treatment. Currant has been suggested for 
the treatment of liver and mesenteric occlusion with dark loose stool and 
poor condition. I have tried it on my patients and found that no exaggeration 
has been made on its effects.”(vol. 3, p.275-276) [13]
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Splenomegaly has also been mentioned by Avicenna in a syndrome with 
splenic enlargement, ascites, dark stool and urine in a patient with dark 
jaundice.
“Dark jaundice is associated with splenic enlargement and stiffness, pain in 
the left side, dark stool and urine … and splenic enlargement causes ascites 
and liver weakness as the spleen absorbs the blood from the liver…”(vol. 3, 
p.236) [13]
Avicenna has mentioned depression and psychosis as other symptoms of 
splenic originated jaundice, which is considered by him a consequence of 
atrabilious humor aggregation in the body because of spleen dysfunction.
“In the splenic originated jaundice, the patient has unexplained depression 
and hallucination …”(vol. 3, p.236) [13]
Avicenna quotes the poor prognosis of such patients from Hippocrates:
“Some types of jaundice are of poor prognosis and are extremely fatal. In 
these cases, the patients have red particles in urine, chills and fever, abdom-
inal cramp, vertigo and inability to speak properly. Such patients will expire 
in 14 days.”(vol. 3, p.234) [13]
He also mentioned hepatic pathologies in differential diagnosis of pa-
tients with “Sobat” (coma) in the chapter of brain diseases and recommended 
focusing on treatment of hepatic pathology in this kind of coma.
“Soddat al-Kabed” therapeutic approaches from Avicenna
Avicenna suggested different therapeutic approaches in patients with 
Soddat al-Kabed including single and compound herbal formulations, dietary 
recommendations, enema, phlebotomy and herbal compresses on liver area.
“We need drugs with diuretic and laxative properties in the treatment of 
Soddat al-Kabed. When the occlusion is in the convex side of liver (post-he-
patic), use the diuretics and when the occlusion is in the concave side (pre-he-
patic), use the laxatives. … The potent complicating diuretics should not be 
used and a diuretic with mild effects should be selected.”(vol. 3, p.185) [13]
He also made some dietary recommendations:
“The patients should abstain from meat, refined bread, wine, rice, salt-pro-
cessed foods, Khash (a traditional dish of boiled cow and sheep heads 
and feet in western Asia). He should also abstain from bathing, exercising 
and drinking large amounts of water after meal.”(vol. 3, p.187) [13]
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Avicenna has mentioned both diuretics and laxatives in the treatment 
of these patients, with different concepts of their mechanism of actions. 
His recommendation against the use of potent diuretics, salt cured foods 
and drinking large amount of water shows his clinical experience in these 
patients. Not being aware of the effects of low protein diet, Avicenna’s di-
etary recommendations against meat also adjust his patient’s diet to be of 
low proteins. 
Avicenna also recommended numerous herbs in “Canon of Medicine” 
some of which are presented in Table 1.
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Numerous primary documented reports of the findings on the portal 
system and portal hypertension appear in the western medicine from the 
16th to 20th centuries with definite descriptions of splenomegaly, ascites, and 
gastrointestinal hemorrhage in the nineteenth century. Vesalius is generally 
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believed to have presented the first depiction of the portal system and its clas-
sification followed by Glisson having introduced portal vein and its function 
based on an animal model. 
Based on the findings from the Canon of Medicine, Avicenna (980-1037 
AD), presented the detailed anatomy of the portal venous system and its feed-
ing branches much earlier than his western counterparts. Most of these de-
scriptions precisely match their current anatomical knowledge. In addition, he 
also presented the anatomic and physiologic association between portal and 
hepatic vein through liver sinusoids. Notably, he presented clinical, etiological 
and therapeutic concepts of portal hypertension under the name of “Soddat 
al-Kabed”. His description of the manifestations of portal hypertension are ac-
curate and comprehensive, and he explained signs like sense of heaviness in 
the liver area with or without mild pain, anemia, pale and inappropriate body 
color, and loose stool. Furthermore, he mentioned ascites, infection, fever and 
abdominal pain (probably, clinical characteristics of the secondary bacterial 
peritonitis) as the possible complications of portal hypertension.
Avicenna was not the only scholar of both Antiquity and the Medieval 
Age who discussed on the anatomy, physiology and diseases of the liver and 
portal system. The liver was known as blood-rich organ among Egyptians, 
Babylonians and Mediterranean people since antiquity [31]. It seems that 
their knowledge of anatomy of liver originated from the inspection of sac-
rificed animals in rituals of divination [32]. The liver was considered as the 
“seat of life” and named with the terms similar to the term “life” in Indian, 
German and English languages [33]. Greek and Roman practitioners con-
sidered the liver as one of the three main organs, along with the brain and 
the heart. Aristotle believed that the vena cava supplies the liver with blood 
from above. Galen, in contrast, considered the liver as the source of blood 
production which supplies other organs with blood through veins. Medieval 
scholars mostly followed Galen idea about the liver and considered it as the 
origin of Natural Power and also source of production of four humors which 
was send through veins for body nourishment and growth [34]. Galen also 
reported from his Alexandrian ancestors about connecting channels in the 
liver between portal vein to the vena cava. The Greek and Roman differ-
entiated portal, caval and biliary vessels in the liver. Liver obstruction was 
also described by Galen as the coagulation of the yellow bile in bile ducts 
which can lead to jaundice [35].  However Avicenna seems to be the first who 
mentioned the possible obstruction in the portal system and its consequent 
complications and manifestations such as ascites and gastrointestinal bleed-
ing in details. 
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Sažetak
Povijesna literatura o portalnoj hipertenziji uglavnom je usredotočena na suvremeni na-
predak u terapijskim metodama, posebice kirurškim. Čini se, međutim, da ljudsko znanje 
o portalnom sustavu, njegovo povezivanje sa sustavom šuplje vene, patologije opstrukcija u 
tom sustavu i gastrointestinalno krvarenje zbog bolesti jetre može biti znatno starije nego što 
se prije vjerovalo.
Avicenna je dao detaljnu anatomiju portalnoga venskog sustava i njegovih grana u Kanonu 
medicine. Soddat al-Kabed va al-Masarigha (jetra i okluzija mesenterijskih žila) bolest je 
koju je Avicenna predstavio kliničkim, etiološkim i terapeutskim opisima koji upućuju na to 
da ima puno sličnosti s identificiranim pojmom “portalne hipertenzije”.
Avicenna je istaknuo osjećaj težine u području jetre s blagom boli ili bez nje, anemiju, blijedu 
i neodgovarajuću boju tijela te mekanu stolicu koja se može zakomplicirati ascitesom, infek-
cijom, groznicom i bolovima u trbuhu kao kliničkim manifestacijama ove bolesti. Predložio 
je i terapeutske pristupe, uključujući laksativ i diuretičke trave, kako bi se izbjeglo izlučivanje 
opstruktivnih tvari u stolici ili urinu.
Ključne riječi: portalni sustav, portalna hipertenzija, anatomija, povijest medicine, 
Avicenna, jetra, tradicionalna perzijska medicina
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